cepia

Clinical Epidemiology and Ageing

Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.

Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F Br J Haematol. 2021;193(3):674-677.
MeSH terms: Adult; Aged; Aged, 80 and over; Bridged Bicyclo Compounds, Heterocyclic; Female; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Retrospective Studies; Sulfonamides
DOI: 10.1111/bjh.17380
PubMed Google Scholar